Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care.

Right to Contraception Act (S. 422/H.R. 999) A resolution expressing the sense of the Senate that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. (S.J. Res. 732) Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. (H.J. Res. 1285) EACH Act (S. 2377/H.R. 4611) Right to IVF Act (not yet introduced) FACE Act Repeal Act (H.R. 589) Reproductive Health Care Accessibility Act (H.R. 8829/S. 4540) To express the Sense of Congress with respect to safety of medication abortion and Federal preemption of State restrictions on dispensing medication abortion, and for other purposes. (H.R. 8734) Freedom to Travel for Health Care Act of 2026 (S. 4701) SAFE Training for OBGYNs Act (H.R. 9441) Let Doctors Provide Reproductive Health Care Act (S. 4879/H.R. 9445) Reproductive Health Travel Fund Act of 2026 (S. 4922) Reproductive Health Care Training Act (S. 4878) Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. (H.Res.1389) SAFER Health Act of 2026 (S. 4920/H.R. 9470)

Client expense: $652,972 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Support for reproductive rights in the following legislation and government actions: H.R. 4104 / S. 2149, Health Equity and Access under the Law (HEAL) For Immigrant Families H.R. 4611 / S. 2377, Equal Access to Abortion Coverage in Health Insurance (EACH) Act H.R. 12 / S. 2150, Womens Health Protection Act (WHPA) H.R. 2029 / S. 951, Stop Comstock Act H.R. 5202 / S. 1598, BABIES Act H.R. 6394 / S. 1599, Midwives for MOMS Act of 2025 H.R. 8074 / S. 4195, Kira Johnson Act H.R. 8089 / S. 4186, Perinatal Workforce Act H.R. 8582 / S. 4436, Protecting Human Rights and Public Health in Foreign Assistance Act H.R. 8807 / S. 4550, Maternal Health Pandemic Response Act H.R. 9470 / S. 4920, SAFER Health Act of 2026 H.R. 4876, Reproductive Freedom for Veterans Act H.R. 9441, SAFE Training for OB-GYNs Act H.R. 211, Equal Access to Contraception for Veterans Act Offered as an amendment to H.R. 8469 - Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. S. 3799, Healthy Start Reauthorization Act of 2026 S. 4574, MARCH for Military Servicemembers Act H.J.Res. 144 / S.J.Res. 103, Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Veterans Affairs relating to "Reproductive Health Services". Advocating for the use of science and accurate data to support decision-making in government policy with respect to mifepristone Providing feedback about provisions impacting reproductive rights in the following legislation: H.R. 7973, Momnibus Act H.Res. 1277, Resolution on Human Rights H.Res. 1389, Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care. Opposing provisions impacting reproductive rights in the following legislation: H.R. 1, One Big Beautiful Bill Act, Section 71113 "Federal Payments to Prohibited Entities. Advocacy regarding the impact of Section 71113 and urging Congress not to reinstate or extend the one-year Medicaid funding restriction affecting Planned Parenthood and Maine Family Planning H.R. 8800, National Defense Authorization Act for Fiscal Year 2027 H.R. 8469, Making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2027, and for other purposes. Opposing all provisions in the following legislation or administrative actions: Department of Veteran Affairs, VA 38 CFR Part 17 RIN 2900-AS31 H.R. 589, FACE Act Repeal Act of 2025 S. 4873, Promoting Human Flourishing in Foreign Assistance Act "Anti-Weaponization Fund that could benefit individuals convicted of violating the FACE Act.

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

-Standing call with Senate staff on reproductive health and rights issues -H.R. 4611- The EACH Act- urged House and Senate offices to cosponsor the bill -H.Res.1389 Expressing the sense of the House of Representatives that the monitoring and regulation of water systems not be weaponized for the purposes of surveilling, tracking, or detecting use of, stigmatizing, and further restricting access to medication abortion care- met with staff and drafted text -Reproductive Health Travel Fund Act (not yet introduced)- worked on drafting text -S.Res.732 / H.Res.1285 Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science. Reviewed and endorsed legislation -S.4701 Freedom to Travel for Health Care Act of 2026- Reviewed and endorsed legislation - Health and Location Data Protection Act (not yet introduced)- Reviewed and endorsed legislation - H.R.9470 SAFER Health Act- Reviewed and endorsed legislation - S.4701 Freedom to Travel for Health Care Act of 2026- Made social media in support of bill, social media content development -S. 4922- Reproductive Health Travel Fund Act of 2026- social media content development - H.R. 9441- SAFE Training for OBGYNs Act- Endorsed legislation - HR 999 Right to Contraception Act- Supported discharge petition - Abortion is Healthcare Everywhere Act (no bill number yet)- met with staff to discuss bill reintroduction

Client expense: $9,749 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE